SIC
RNAM

Salem Investment Counselors’s Avidity Biosciences RNAM Stock Holding History

Salem Investment Counselors’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35
Closed -$389 – 1164
2023
Q2 		$389 Hold
35
– – ﹤0.01% 1096
2023
Q1 		$538 Hold
35
– – ﹤0.01% 1053
2022
Q4 		$777 Hold
35
– – ﹤0.01% 1008
2022
Q3 		$1K Hold
35
– – ﹤0.01% 1009
2022
Q2 		$1K Hold
35
– – ﹤0.01% 1039
2022
Q1 		$1K Hold
35
– – ﹤0.01% 975
2021
Q4 		$1K Hold
35
– – ﹤0.01% 1045
2021
Q3 		$1K Hold
35
– – ﹤0.01% 947
2021
Q2 		$1K Buy
+35
New +$814 ﹤0.01% 875

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Salem Investment Counselors's RNAM Position: Q3 2023 in Review

Salem Investment Counselors sold out of Avidity Biosciences (RNAM) in Q3 2023, closing a stake of 35 shares — an estimated $389 sold.

Salem Investment Counselors first reported a position in RNAM in Q2 2021 and held it in 9 quarters. The position peaked at $1K in Q3 2022. 142 funds tracked by Wall St. Rank hold RNAM as of Q3 2023.

  • Salem Investment Counselors reported no remaining Avidity Biosciences position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 35 Avidity Biosciences shares in Q3 2023, an estimated $389.
  • Salem Investment Counselors first reported a position in Avidity Biosciences in Q2 2021 and held it in 9 quarters.
  • Salem Investment Counselors's Avidity Biosciences position peaked at $1K in Q3 2022.
  • 142 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.